WARF Therapeutics’ portfolio includes innovations tied to “theranostics,” a term for delivery of radioactive drugs that can be diagnostic and therapeutic in the same dose. In short, it’s about pinpoint targeting of potentially malignant cells for both diagnosis with one drug and destruction with another.
Office of Strategic Communication